WG Kaelin

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

A. Kibel, W. Kaelin, J. Decaprio, 1995, Science.

Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma

C. Stolle, A. Sorrell, J. Ellenhorn, 2011, Clinical genetics.